Clinical Trial Update: Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fluid prophylaxis strategies to prevent Contrast Induced Nephropathy was withdrawn from the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Memorial University of Newfoundland | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: WITHDRAWN